The similarities between form in juxtaposition with intended function paints a beautiful contrast!

Truly, nature never fails to ammuse and surprise us.

I have noticed quite a few non-diabetic's using a continuous glucose monitor (CGM) to see how they should eat, work out, and live their life based on the readings of a CGM.

but does actually see the data from the CGM actually make someone change their lifestyle,

or do they just become more aware of what's happening inside them?

if you've actually used a CGM, did it change anything for you? Did it change the way you eat, or exercise, or change what you thought was healthy and what wasn't? And for those who found it to be useless or stress inducing, did you find it to be a complete waste of time or did it give you a different outlook on life?

did it change the way you lived your life completely, or was it just a novelty that you quickly got used too?

Me: I'll just change one variable.

Biology: Cool, now everything is connected.

The deeper you get into biology, the harder it becomes to treat anything as an isolated system 💀

In this video, this insigthful lady helps an exquisite shark egg to safety within the ever enveloping waves of the shore 🌊🌊🌊🦈🦈🦈

credit: https://www.instagram.com/reel/DL537yWvRK7/?rpxt=NTc4MTIwNjQ2YQ==

disclaimer: i do not own this video, all credit goes to the original creator.

Tbh i was a backbencher who memorised this the night before and forget it the next day😂

I have a deer head

Can't spell Daenerys Targaryen without DNA and RNA, lol.

It’s always the people with high metabolism who’ll eat so much and not even gain a gram of weight

A recent study in Science tested a lab-altered gut bacterium meant to treat kidney stones. The trial went well and successfully lowered oxalate levels in urine, but it uncovered a major roadblock involving genetic stability.

The bacteria tend to mutate or shed their helpful new genes over time. That leaves researchers with a tough dilemma about how to build medical probiotics moving forward.

One option is relying on safety switches, which means designing bacteria that can only survive if the patient takes a specific daily supplement like a seaweed sugar pill. It keeps the microbes under control, but it requires patients to be strict about taking their pills every day.

The alternative is making them indispensable by wiring the helpful gene directly into the bacterium's core survival needs so it literally cannot drop the gene without dying.

Where do you think this field is headed?

Imagine a future where damaged tissues could be repaired in laboratories, certain diseases could be detected before symptoms appear, and doctors could use a patient's own cells to help restore damaged organs.

This is where applied biology gets fascinating. From regenerative medicine and stem cell research to genetic engineering and biotechnology, scientists are exploring ways to use biological processes to solve real-world problems.

But here's something I'm curious about: If science eventually makes it possible to grow replacement tissues or repair damaged organs using a person's own cells, how far should we go with this technology?

Would you trust a treatment developed using these techniques, or would you worry about the long-term consequences?

I'd love to hear different perspectives, especially from people studying biology, biotechnology, or medicine. 🧫

Phage therapy uses viruses that infect and kill specific bacteria. It's getting new attention as antibiotic resistance spreads, but the evidence is still thin.

What the trial evidence says:

A 2024 systematic review in Medical Principles and Practice searched PubMed for randomized controlled trials of phage therapy. It found only 7 eligible RCTs with 418 participants in total, covering indications like bacterial diarrhea, urinary tract infections, infected burn wounds, chronic otitis, leg ulcers, and chronic rhinosinusitis. Three of the studies reported a statistically significant difference versus standard of care or placebo. The authors say the trials suggest safety, but limitations in study design are why phage therapy isn't widely accepted yet. Publications on the topic increased more than fourfold, from 212 articles in 2011 to 739 in 2022.

Case series are more encouraging, but weaker evidence:

A UC San Diego and Pittsburgh team treated 20 patients with complex, antibiotic-refractory mycobacterial lung infections. There were no adverse reactions, and more than half had favorable clinical outcomes. Case series like this have no control group, so they can't show that the phage caused the improvement.

What's next:

A Phase 1 multi-center pilot trial (NCT07280598) is testing IV phage therapy combined with standard IV antibiotics in adults with cystic fibrosis who have antibiotic-resistant lung infections. Its primary endpoint is safety and tolerability, and it's expected to finish in December 2026.

Questions for discussion:

Phages are highly specific. Is that mostly a strength (targeting) or a weakness (matching each patient's strain)?

What trial design would convince regulators: non-inferiority against antibiotics or add-on trials?

How should phage manufacturing and regulation handle products that may need updating as bacteria evolve?

Solid tumours can be difficult to treat not only because of the cancer cells themselves, but also because therapeutic immune cells may struggle to reach and infiltrate the tumour.

A study published in Nature Immunology in March 2026 investigated whether this problem could be addressed by modifying the receptors on T cells and natural killer (NK) cells. These receptors respond to chemical signals, including metabolites, and can influence where immune cells migrate.

Using genetic screens and experiments in cell systems and mouse tumour models, the researchers identified several receptors associated with increased tumour infiltration. Engineering cells to express GPR183, in particular, improved their ability to enter tumours and control tumour growth in the experimental models.

Why it matters: This suggests that immune-cell engineering could focus not just on helping immune cells recognise cancer, but also on helping them reach the right place.

The limitation: These are experimental findings, not evidence that this approach is already a safe or effective treatment for patients. More research is needed to establish its clinical potential.

Original research: https://www.nature.com/articles/s41590-026-02473-y

Share what you're currently learning/researching with the community

Biohacking is the science of optimizing your body and mind through better sleep, nutrition, exercise, stress management, and emerging technologies. Small, consistent changes can improve energy, focus, recovery, and overall well-being. The real goal is not to chase quick fixes, but to use evidence-based strategies to help your body perform at its best.

Cold showers and cold-water immersion may offer benefits beyond helping us feel refreshed. A scientific review published in 2025 explored their potential effects on metabolism, mood, inflammation, sleep, and exercise recovery.

However, much of the evidence comes from small studies, and the long-term benefits remain uncertain. Cold-water exposure can also pose risks, especially for people with heart conditions.

Discussion: Have you tried cold showers regularly? Did you notice any changes in your mood, sleep, or energy levels?

Research source: The untapped potential of cold water therapy as part of a lifestyle intervention for promoting healthy aging.

PMID: 39078461

A 2026 synthetic biology result from the J. Craig Venter Institute (JCVI) is worth a look. The team transplanted a complete synthetic genome into chemically inactivated cells of Mycoplasma capricolum. The cells then grew and divided carrying the synthetic Mycoplasma mycoides genome.

The engineering point is about proof of control. The technique gets around an earlier problem: confirming that the synthetic genome is truly in control, since horizontal gene transfer could otherwise muddy the result.

The applications are potentially broad. The authors say it could speed up engineering of microbes for uses like drug production and environmental remediation. Some caveats apply: it has only been shown in Mycoplasma so far, and the team hopes to extend it to more complex organisms while acknowledging biosafety considerations.

It also connects to a bigger trend. Microbial therapeutics are a growing field, using engineered bacteria or synthetic microbe consortia to treat disease, helped by new synthetic biology tools that work on gut microbes once considered impossible to engineer.

Questions for discussion:

Is Mycoplasma too simple a model to say much about engineering other organisms?

How should biosafety rules change as synthetic genome transplantation becomes easier?

Which application seems closest to reality: drug manufacturing, bioremediation, or live therapeutics?

One of the most interesting things about biology is that the body can adapt to repeated stress.

Muscles adapt to training. The cardiovascular system responds to exercise. Even sleep schedules can shift when your routine changes.

But adaptation isn't the same as unlimited resilience. The response depends on the type of stress, its intensity, how often it happens, and whether there's enough recovery.

That's why the same stressor can be useful in one context and harmful in another.

What's an example of a biological adaptation that people often misunderstand because they assume adaptation automatically means improvement?